EMEA-000987-PIP01-10-M04

Table of contents

Key facts

Invented name
Strensiq
Active substance
asfotase alfa
Therapeutic area
Endocrinology-Gynaecology-Fertility-Metabolism
Decision number
P/0176/2019
PIP number
EMEA-000987-PIP01-10-M04
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of hypophosphatasia
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Alexion Europe SAS

Tel. +33 153643800
E-mail: pip.enquiries.eu@alexion.com

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000987-PIP01-10-M04
Compliance opinion date
18/10/2019
Compliance outcome
positive

Decision

Related content

How useful was this page?

Add your rating